Document Detail


Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial.
MedLine Citation:
PMID:  20691834     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Circulating levels of osteoprotegerin (OPG), a member of the tumor necrosis factor receptor superfamily, is predictive of death and hospitalization for heart failure after acute coronary syndrome. The association between OPG and outcome in patients with chronic heart failure (CHF) is unknown. METHODS: Plasma OPG levels at baseline were assessed in 1,229 patients with CHF recruited from 51 clinical centers and included in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Heart Failure (GISSI-HF) trial. Patients were randomized to n-3 polyunsaturated fatty acids (1 g/d) or rosuvastatin (10 mg/d) versus placebo. Osteoprotegerin was analyzed by enzyme-linked immunosorbent assay. The association between OPG and outcome was assessed by Cox proportional hazards regression models. RESULTS: During a median follow-up time of 3.9 years, 332 patients died; and 791 patients died or were hospitalized because of cardiovascular causes. By univariate analysis, baseline OPG levels were strongly associated with the incidence of death (hazard ratio {HR} [95% CI] 1.53 [1.40-1.67] per 1-SD increase in log OPG). After adjustment for conventional risk markers, OPG remained a significant predictor of death (HR [95% CI] 1.20 [1.06-1.35], P < .001). Similar findings were observed for the composite end point (HR [95% CI] 1.34 [1.07-1.69], P = .012). CONCLUSION: In patients with CHF, OPG is associated with the incidence of death independently of conventional cardiovascular risk factors.
Authors:
Ragnhild Røysland; Serge Masson; Torbjørn Omland; Valentina Milani; Mette Bjerre; Allan Flyvbjerg; Giuseppe Di Tano; Gianfranco Misuraca; Aldo P Maggioni; Gianni Tognoni; Luigi Tavazzi; Roberto Latini;
Related Documents :
16582544 - Medical and ventilatory treatment of acute heart failure: new insights.
18648724 - Low night-to-night variability of sleep disordered breathing in patients with stable co...
15561254 - Heart transplantation in the patient under ventricular assist complicated with device-r...
18237604 - Analysis of 150 patients with carcinoid syndrome seen in a single year at one instituti...
1748754 - Acute and chronic ischemia of the hand: pathophysiology, treatment, and prognosis.
18204184 - Quality of life of patients with diseases of sinuses.
Publication Detail:
Type:  Journal Article; Multicenter Study; Randomized Controlled Trial    
Journal Detail:
Title:  American heart journal     Volume:  160     ISSN:  1097-6744     ISO Abbreviation:  Am. Heart J.     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-08-09     Completed Date:  2010-09-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  286-93     Citation Subset:  AIM; IM    
Copyright Information:
Copyright 2010 Mosby, Inc. All rights reserved.
Affiliation:
Division of Medicine, Akershus University Hospital, Lørenskog, Norway.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Female
Fluorobenzenes / therapeutic use
Fluoroimmunoassay
Heart Failure / blood*,  drug therapy,  mortality*
Hospitalization / statistics & numerical data
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Italy
Male
Middle Aged
Osteoprotegerin
Prognosis
Proportional Hazards Models
Pyrimidines / therapeutic use
Sulfonamides / therapeutic use
Chemical
Reg. No./Substance:
0/Fluorobenzenes; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0/Osteoprotegerin; 0/Pyrimidines; 0/Sulfonamides; 287714-41-4/rosuvastatin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Serum albumin concentration and heart failure risk The Health, Aging, and Body Composition Study.
Next Document:  Correlation of heart-type fatty acid-binding protein with mortality and echocardiographic data in pa...